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Introduction: Patients receive information about their medication from different sources,
includingprescription labels. These labels arephysically attached toeachpackagedispensed
to patients and contain the most important instructions on how to use the medication
correctly. However, many patients experience difficulties in understanding and applying the
instructionson these labels correctly, especially patientswith limitedhealth literacy. Theaimof
this study is to investigate the comprehensibility of prescription label instructions among
patients with adequate and limited health literacy skills, and to implement improvements in
primary health care.
Methods: We used a mixed-methods approach, which consisted of four phases. Phase 1
(desk research) was divided into a systematic literature review on the comprehensibility of
prescription label instructions (1a) and a content analysis of the textual elements in Dutch
prescription label instructions (1b). In phase 2 (patient studies), semi-structured interviews
were conducted to investigate the comprehensibility of seven prescription labels among
patients with different health literacy skills (2a), and a quantitative study in which the
comprehensibility of six optimized prescription labels was compared among patients with
different health literacy skills (2b). Patient studies were conducted in eight Dutch pharmacies.
In phase 3 optimized prescription label instructionswere implemented in national medication
databaseswhichhasbeensupportedbyaguideline (3a), andeducationofpharmacyworkers
(3b). Phase 4 consists of evaluating the optimized prescription label instructions by
experiences from patients and pharmacists.
Anticipated Results: This mixed-methods approach will result in scientific publications
of the individual studies, and a guideline on how to compose comprehensible prescriptionin.org July 2020 | Volume 11 | Article 9811
Abbreviations: GP, General practitioner; N
RALPH, Recognizing and Addressing Lim
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Frontiers in Pharmacology | www.frontierslabel instructions to be put on medication packages. Optimized prescription label
instructions will be implemented in national medication databases.
Discussion: This protocol describes a mixed-method research to compose and
implement comprehensible prescription label instructions and will lead to knowledge
about the comprehensibility of textual elements in these labels, with specific attention for
patients with limited health literacy. Implementation of optimized prescription label
instructions will lead to a better understanding of them, which may contribute to
improved medication adherence. A limitation is that non-textual aspects of prescription
labels are not investigated.Keywords: prescription label instructions, comprehensibility, health literacy, mixed-methods, systematic review,
textual content analysis, patient studies, implementationINTRODUCTION
Instructions on how to use medication are an essential part of
patients’ medication management. Patients receive instructions
about their medication use from different sources. Dosing
instructions are provided by the prescriber, both verbally and
written on a prescription. Written information is available in the
package insert of the manufacturer and on the package itself
(Raynor and Bryant, 2013; van Beusekom et al., 2016).
Internationally, the package leaflet is the most common source
of written information, with many studies covering this topic,
and regulatory requirements concerning the content and
comprehensibility of the text (Raynor and Bryant, 2013; Pires
et al., 2016; Yuan et al., 2019). These requirements have been
developed to ensure the information about medication on the
outer package and the package leaflet is accessible, and written in
plain language that can be understood by patients, including those
with limited health literacy (European Commission, 2009a). The
European Union requires in-depth user tests on the package
leaflets’ comprehensibility before marketing authorization is
granted (European Commission, 2009b; Van Dijk et al., 2014).
In addition, in many countries the pharmacist composes a
prescription label with directions for medication use, comprising
of information related to the individual patient (name/address/date
or birth), medication (name, strength, and amount of active
substance), and health care professionals involved (prescriber,
pharmacy) (Lester et al., 2013). In the Netherlands, the pharmacist
attaches this label to the medication package for each prescription,
and dispenses the product with additional verbal instructions (van
Hulten et al., 2011). In other countries, such as Germany, patients do
not get personalized prescription label instructions, and physicians
are not obliged to write specific dosage or auxiliary instructions on
the prescriptions (Botermann et al., 2016).
The prescription label serves as an independent, comprehensible
information source supporting patients’ correct medication use
which in turn could facilitate their medication therapy (Webb
et al., 2008). Prescription labels contain dosage instructions and
auxiliary instructions (Wolf et al., 2007).Dosage instructionsdescribeVS-d, The Newest Vital Sign in Dutch;
ited PHarmaceutical Literacy.
in.org 2how patients should use the medication, the intake frequency, and
the number of units per intake (e.g., “take two capsules twice daily”).
Auxiliary instructions consist of warnings (e.g., “Do not drink
alcoholic beverages”) and advices (e.g., “take with food or milk”).
Currently, the size and design of medication packages limit the
amount of available space for prescription labels which means that
only the most essential instructions are presented in a concise way.
The combinationof limited space, and the complexity of information
needed to informpatients about proper use ofmedication, challenges
the pharmacist to compose a prescription label instruction that is
both informative and comprehensible. In contrast to the package
leaflet, there are, as far as we know, no guidelines that provide
directions on how to compose comprehensible instructions for the
prescription label (European Commission, 2009b).
Research has shown that prescription labels may cause problems
because they are often misinterpreted, which may lead to incorrect
medication use (Davis et al., 2006a; Davis et al., 2006b; Wolf et al.,
2006; Bailey et al., 2009; Wolf et al., 2010; Wolf et al., 2011; Bailey
et al., 2014). One of the causes for misinterpretation is the wording
of the instructions, which appears to be too difficult for patients,
especially for those with limited health literacy (Beckman et al., 2005;
Shrank et al., 2007; Bailey et al., 2012; Koster et al., 2014). Health
literacy can be defined as the skills to obtain, understand, and use
health information in order to enhance health, well-being, and active
involvement in medical decision making (Sorensen et al., 2012).
Research shows approximately 25% of the Dutch population has
limited health literacy (Consortium, 2012). Limited health literacy is
associated with negative health outcomes and poor ability to
understand instructions of prescribed medication (Davis et al.,
2006a; Lo et al., 2006; Wolf et al., 2007). Therefore, prescription
labels instructions should be presented in an unambiguous and clear
way (Bailey et al., 2009). Moreover, it is important to take health
literacy into account when evaluating the comprehensibility of
prescription label instructions [c.f., (Patel et al., 2018)].
However, it is unknown how specific textual elements in
prescription label instructions (e.g., the presentation of numbers
or use of plain language) and patients’ health literacy skills are
related to their comprehension. Although Samaranayake and
colleagues (Samaranayake et al., 2018) conducted a narrative
review in which they discuss studies focusing on patient-related
(age and literacy) and medication-label related factors (i.e., the useJuly 2020 | Volume 11 | Article 981
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comprehensibility of prescription labels instructions, an overview
of specific textual elements associated with better comprehension
of prescription label instructions was not provided. Knowledge of
which textual elements facilitate patients’ comprehension of
prescription label instructions, especially those with limited
health literacy, will provide concrete directions for health
professionals on how to optimize their medication prescriptions.
Moreover, research of Borgsteede and Heringa (2019) showed a
substantial proportion of Dutch prescription label instructions was
too complex, and could be optimized by rephrasing them. For
example, of the 100most frequently used dosage instructions, 23.8%
were instructions for multiple times a day use without specifying the
time of day (e.g., “1 tablet 2 times a day”), and 13% contained
general instructions or instructions to “take as needed.”Arguably, as
the instructions were about one-third of the total, the potential
improvement on a population level is significant. To improve the
comprehensibility of prescription label instructions, it is important
to study how the textual elements as well as patients’ health literacy
are related to correct interpretation of prescription label
instructions. In this study, we aim to analyze, optimize, and
implement comprehensible prescription label instructions in the
Netherlands by using a mixed-methods approach, and to provide a
study protocol for other countries to develop comprehensible
prescription label instructions.MATERIAL AND METHODS
Design
The study consists of four phases (see Figure 1) and started in
January 2017. Data collection for the literature review andFrontiers in Pharmacology | www.frontiersin.org 3content analysis (phase 1) and patient studies (phase 2) have
been finished, and the implementation of outcomes is ongoing.
In December 2021 we expect to finish Phase 4.
We have tested the comprehension of prescription label
instructions in eight pharmacies across the Netherlands and
included patients with different education levels and health
literacy levels. Based on the studies in the four phases, we
optimized prescription label instructions, and implemented and
evaluated them in primary care in the Netherlands. Prescription
label instructions have been optimized and implemented in the
national medication databases which are used to prescribe and
dispense medication. Also, a guideline has been provided on how to
compose comprehensible prescription label instructions.
By using a mixed-methods approach and with the supervision
of a multidisciplinary expert panel, we investigated this problem
from three different perspectives, i.e., literature, linguistics, and
patients. It is recommended to involve the target group when
designing and evaluating health information (van Beusekom
et al., 2018). Therefore, we included patients within the patient
studies, with respect to health literacy. The mixed-methods
approach enabled us to investigate the comprehensibility of
prescription label instructions using both qualitative and
quantitative research methods, in which we included patients’
interpretations to expand and strengthen the study conclusions
(Schoonenboom and Johnson, 2017).
Setting
Dutch community pharmacies use pharmacy information systems
with clinical decision support. These systems contain a centrally
maintained table with codes and corresponding dosage instructions.
Moreover, they contain a table with predefined auxiliary labels for
all available medicines (Borgsteede et al., 2019). In general, aFIGURE 1 | Flow chart of the four phases research on the study, development, implementation, and evaluation of comprehensible prescription label instructions.July 2020 | Volume 11 | Article 981
Maghroudi et al. Development of Comprehensible Prescription Label Instructionsprescriber provides patients with dosage instructions, which are a
part of an electronic prescription. Next, a pharmacist processes the
prescription and can either use a predefined dosage code, or use free
text for the dosage instructions on the prescription label. Auxiliary
labels are automatically printed on prescription labels, although
the pharmacist has the discretion to overrule the labels in
individual cases. Both the prescriber and pharmacist explain to
patients how to use the medication. Written information is also
provided by means of the package leaflet of the manufacturer and
a patient-centered information leaflet.
Health Literacy
Wehave included a representative sample of patients including both
patients with limited and adequate health literacy skills. The
interviewer followed a training on communication with patients
with limited health literacy to recruit them for this study, and to
support them infinishing the interview.We recruitedpharmacies for
the interviews which serve a diverse patient population with respect
to health literacy. The Pharos Dutch Centre of Expertise on Health
Disparities supported in selecting these pharmacies. To assess health
literacy levels among patients, two assessment tools were used: The
Newest Vital Sign in Dutch [NVS-d; (Fransen et al., 2014)], and The
Recognizing and Addressing Limited Pharmaceutical Literacy
(RALPH; (Koster et al., 2018; Vervloet et al., 2018).
Expert Panel
In all phases, an expert panel has been consulted. The panel
consisted of primary health care professionals (pharmacists,
physicians), health literacy experts, an expert in linguistics, experts
in pharmacy practice research, a patients’ representative, and
pharmacists working with the national medication databases. The
expert panel met prior to each phase. Results of each phase have
been presented to and commented on by the expert panel. After
implementing our results, the expert panel will maintain their efforts
concerning comprehensible prescription label instructions by
annual evaluation of reports. The underlying guidelines will be
revised in consultation with the expert panel every 5 years.
Phase 1a (Theoretical Framework):
Literature Review on Comprehensible
Prescription Label Instructions
Rationale: International studies have investigated the
comprehensibility of prescription label instructions. The results
show different textual elements impact the comprehensibility ofFrontiers in Pharmacology | www.frontiersin.org 4prescription label instructions. Also, patients’ interpretations of
specific textual elements might differ, due to their health literacy.
The systematic literature review was conducted in 2018 and
provided directions on how prescription label instructions can be
optimized according to current scientific insights.
Aim: To identify the role of textual elements and health literacy
on the comprehensibility of prescription label instructions.
Data collection: Electronic searches of published literature were
conducted in four databases: PubMed, Embase, PsychINFO, and
SmartCat. These databases were searched without time restrictions
inEnglish andDutch language via the strategies outlined inTable1.
Studies were included if they discussed the comprehensibility of
prescription label instructions and addressed textual elements of the
prescription label instructions, such asmedical jargon, abbreviations,
the spelling of numbers (alphanumerical or numerical), and
complexity and precision of dosage instructions. Studies focusing
solely on the relation between the comprehensibility of prescription
label instructions and the use of icons, fonts, format of the label, the
way of printing, or other graphical elements, were excluded. Due to
technical reasons of the printing systems,we could only adapt textual
elements in prescription label instructions in this project. Moreover,
one reviewer checked reference lists of the retrieved articles, in order
to include relevant articles.
Analysis: We identified textual elements that impact the
comprehensibility of prescription label instructions. We reported
on the study characteristics, specifically the health literacy skills of
the included patients, and quality of selected publications.
Outcome: We provided an overview of textual elements
which facilitate or hinder the comprehension of prescription
label instructions, complemented with recommendations to
improve the prescription label instructions in practice.Phase 1b (Content Analysis): Explore the
Variability of Currently Used Prescription
Label Instructions
Rationale: In phase 2, prescription label instructions had to be
presented to patients, that needed to be realistic in the context of
medication use, yet had a variety in textual elements and topics
to study differences in patients’ interpretations. Therefore the
systematic literature review was combined with a content
analysis in which we analyzed the variation in the topics and
wording of Dutch prescription label instructions. This content
analysis has been conducted in 2018.TABLE 1 | Search strategy in electronic databases.
Database Search components Search
PubMed Comprehension AND drug labeling OR prescription label ((comprehension[MeSH Terms]) AND drug labeling[MeSH Terms]) OR prescription label
[Title]
PubMed Comprehension OR misunderstanding AND prescription label
OR medication label
“Comprehension” (Mesh) OR misunderstanding (tiab)) AND (prescription label* (tiab) OR
instruction label* (tiab) OR medication label* (tiab) Field: Title
SmartCat Comprehension OR misunderstanding AND medication label
OR prescription label
su: comprehension OR su:misunderstanding) AND (kw:medication label* OR kw:
prescription label*
PsychINFO Comprehension OR misunderstanding AND prescription label
OR medication label OR instruction label
comprehension OR misunderstanding) AND (prescription label* OR medication label* OR
instruction label*
Embase Comprehension OR misunderstanding AND prescription AND
label OR medication AND label OR instruction AND label
(‘comprehension’/exp OR misunderstanding:ti,ab) AND (prescription:ti,ab AND label*:ti,
ab OR (medication:ti,ab AND label*:ti,ab) OR (instruction:ti,ab AND label*:ti,ab))July 2020 | Volume 11 | Article 981
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Dutch prescription label instructions by performing a content
analysis. This analysis informed the composition of prescription
label instructions used in phase 2 (patient studies).
Data collection: We collected the currently used prescription
label instructions from two national medication databases (i.e.,
PharmaBase from Health Base Foundation and G-Standard from
The Royal Dutch Pharmacists Association).
Analysis: All prescription label instructions were analyzed on
the presence of textual elements (based on the findings of the
systematic literature review), and their topics (dosage
instruction, auxiliary label warning, or auxiliary label advice).
Outcome: We gained insights into the frequency of textual
elements used in prescription label instructions as well as the
frequency in prescription label instructions’ topics.
Phase 2a (Patient Studies): Patients’
Interpretations of Prescription Label
Instructions
Rationale : To make prescription label instructions
comprehensible for all patients, it is important to examine how
patients interpret prescription label instructions and which
textual elements facilitate or hinder patients’ interpretation.
Therefore, currently used prescription label instructions and
potential improvements were presented to patients with
limited and adequate health literacy. Their interpretations were
explored thematically. This study has been conducted in 2017.
Aim: To explore patients’ interpretations of currently used
prescription label instructions and potential improvements for
the prescription label instructions, and their opinion on
potential improvements.
Data collection: We included patients, aged 18 years and
older, who could read, and speak Dutch (although fluency was
not required). Patients were approached in the waiting area of
pharmacies serving a diverse patient population with respect to
health literacy. Exclusion criteria were: (1) visual impairments,
not resolvable by reading glasses, and (2) lack of understanding
of the Dutch language. A total of 39 patients were included for
in-person semi-structured interviews. We developed an interview
guideline. Patients’ health literacy skills were measured subjectively
and objectively, using two instruments respectively: The
Recognizing and Addressing Limited PHarmaceutical Literacy
(RALPH) interview guide, and The Newest Vital Sign in Dutch
[NVS-d; (Fransen et al., 2014)]. The Netherlands Institute for
Health Services Research (Nivel) and the Utrecht Pharmacy
Practice network for Education and Research (UPPER) developed
the RALPH instrument (Koster et al., 2018; Vervloet et al., 2018).
We included a varied patient group according to age, gender,
mother tongue, education level, and health literacy level by
purposive sampling. The researcher followed a course at the
Pharos Dutch Centre of Expertise on Health Disparities on
effective communication with patients with limited health
literacy in order to approach and interview patients with
limited health literacy skills.
Patients received verbal information about the study, and an
information sheet with a short description of the study. InFrontiers in Pharmacology | www.frontiersin.org 5consultation with the Medical Ethics Committee, we concluded
that written informed consent was preferred, but verbal—
audiotaped—consent was possible to diminish the participation
barrier for patients with limited health literacy. Interviews were held
in pharmacies’ consulting rooms and were audio-recorded. At the
beginning of the interview, sociodemographic characteristics were
registered. Subsequently, patients interpreted seven medication
labels in a random order, one by one. Medication labels were
designed using a number of prescription label instructions
consisting of various textual elements and varying in complexity
(based on the insights of phase 1a and 1b). After choosing
prescription label instructions, we combined those instructions into
seven realistic prescription label instructions together with existing
medication names. Prescription labels instructions were attached to
medication packages of the specific pharmacy, together with the
name of the medication in order to enhance the labels’ credibility. To
simulate a realistic prescription label, we chose medication that is
frequently prescribed in Dutch primary care, such as non-steroidal
anti-inflammatory drugs, amoxicillin proton-pump inhibitors, beta-
blockers, and statins (Stichting Farmaceutische Kerngetallen (SFK),
2017). Patients had to explain the prescription label instructions in
their own words. Patients interpreted dosage instructions and
auxiliary instructions by responding on the question: “What does
this [prescription label instruction] mean?” To test their
interpretation of the dosage instructions, patients were asked to
demonstrate the moment and amount of medication consumption
on a time schedule with candy resembling medicines. This way,
interpretation and demonstration were measured independently. All
patients received the currently used version of the prescription label
and an optimized one. Patients were askedwhich label they preferred.
Analysis: Audio records of the interviews were transcribed
verbatim and analyzed by the researcher based on a coding
scheme (see Table 2). Patients’ answers were analyzed in terms of
correctness. The various interpretations of patients were also
explored thematically.
Outcome: Based on the initial analysis of data, the systematic
literature review, and the content analysis, prescription label
instructions were optimized.
Phase 2b (Patient Studies): Patients’
Comprehension of Current Versus
Optimized Prescription Label Instructions
Through an Experimental Study
Rationale: In order to test whether prescription label instructions
are comprehensible for patients, it is important to test patients’
comprehension of the currently used and the optimized versions
among patients with different levels of health literacy. This study
has been conducted in 2017.
Aim: To study patients’ interpretations of currently used and
optimized prescription label instructions.
Data collection: Six prescription label instructions with a
variation in textual elements and topics were chosen. Realistic
prescription label instructions were composed conform phase 2a
[i.e. choosing medication that is frequently prescribed in Dutch
primary care (Stichting Farmaceutische Kerngetallen (SFK),
2017)]. Both the currently used and the optimized prescriptionJuly 2020 | Volume 11 | Article 981
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(3 currently used and 3 optimized prescription label instructions).
Based on power calculation (power = 80%, a = 5%), 158 patients
were recruited (79 respondents per test group). Patients were
approached in the waiting area of pharmacies serving a diverse
patient population with respect to health literacy, mother tongue,
and education levels. Patients aged 18 years or older, who could
read and speak Dutch were included. Exclusion criteria were:
(1) visual impairments, not resolvable by reading glasses, and
(2) lack of understanding of the Dutch language.
Patients received verbal information about the study, and
information sheet with a short description of the study. In
consultation with the Medical Ethics Committee, we concluded
that written informed consent was preferred, but verbal—
audiotaped—consent was possible to diminish the participation
barrier for patients with limited health literacy. Sociodemographic
characteristics were registered at the beginning of the interview.
We aimed to have a representative patient group according to age,
gender, mother tongue, education level, and health literacy level.Frontiers in Pharmacology | www.frontiersin.org 6All interviews were audio-recorded. Primary outcome was the
interpretation of the use of the medication according to the
instructions on the medication label. Patients interpreted dosage
instructionsandauxiliary instructionsbyrespondingonthequestion:
“What does this [prescription label instruction] mean?” To test their
interpretation of the dosage instructions, patients were asked to
demonstrate the moment and amount of medicine consumption
on a time schedule with candy resembling medicines. This way,
interpretation and demonstration were measured independently.
Considering the population, we categorized patients’
interpretations using response categories: the researcher chose the
best fitting response category in order to cluster the answers within
categories for further analysis. Thus, we did to not steer patients’
interpretations into the predefined response categories and
prevented we would miss unexpected patients’ interpretations.
Similar to phase 2a, we used the RALPH instrument (Koster
et al., 2018; Vervloet et al., 2018) and NVS-d (Fransen et al.,
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instructions were determined by reviewing patients’ verbatim
responses. Patients’ answers were analyzed based on a coding
scheme (see Table 3) and their interpretations were also be
explored thematically. In addition, the impact of patients’ health
literacy on the correct interpretation of prescription label
instructions were determined.
Outcome: Based on this quantitative study, the proportion of
correct interpretation of textual elements in current and
optimized prescription label instructions were determined, and
were related to patients’ health literacy skills.
Phase 3a and 3b: Implementation
Rationale: We have developed a guideline, a handbook, and a
freely-accessible e-learning course on composing comprehensible
prescription label instructions. These materials have been
developed in 2018.
Aim: To implement knowledge about comprehensible
prescription label instructions in pharmacy practice.
Method: Implementation has been done by developing a guideline
and handbook on composing comprehensible prescription label
instructions, and developing a freely-available e-learning, and an
automated implementation via a national medication database.
Guideline and handbook to compose comprehensible
prescription label instructions: Based on the findings in phases
1 and 2, we formulated recommendations in a guideline on
composing comprehensible prescription label instructions. We
also provided a handbook for pharmacy technicians which helps
them to compose comprehensible prescription label instructions.
Pharmacy assistants’ education: Pharmacy assistants have
been educated in composing comprehensible prescription label
instructions through a freely-accessible e-learning course. This
course was based on the recommendations of the guideline.
Learning goals of this e-learning were:
To create awareness of misinterpreting prescription label instructions,
especially for patients with limited health literacy skills.
To teach pharmacy technicians to translate dosage instructions of
prescriptions into comprehensible prescription label instructions.
Pharmacy Information System: In the Netherlands, prescription
label instructions used in Pharmacy Information Systems in
primary care are from one of two national drug databases:
Pharmabase or G-Standard. These databases are owned by
Health Base Foundation (Pharmabase), and G-Standard (Royal
Dutch Pharmacists Association), with pharmacies using
Pharmabase data covering about 55% of the pharmacies in the
Netherlands (Bahar et al., 2017). For auxiliary label instructions,
optimized prescription label instructions based on the guideline
were implemented in the Pharmabase in January 2018, and for the
G-Standard in March 2020. Optimized dosing instructions cannot
be fully implemented in the software of Pharmacy Information
Systems due to technical requirements, and is supported by the
guideline and e-learning course.
Phase 4: Evaluation
After implementing the optimized prescription label
instructions, comments and suggestions from health careFrontiers in Pharmacology | www.frontiersin.org 7professionals and patients will be analyzed. The Health Base
Foundation manages the Pharmabase and receives comments
and suggestions by phone and email from pharmacists,
pharmacy assistants, general practitioners, and patients. The
comments will be ordered according to type of prescription
label instructions (dosage instructions/auxiliary label), topic, and
textual elements. Comments will be analyzed systematically to
identify similar underlying factors associated with limited
comprehension of prescription labels, and suggestions for
improvement will be reviewed and discussed with the expert
panel. If necessary, additional qualitative and quantitative studies
will be performed in pharmacy practice to compose
comprehensible prescription label instructions. We will
continue to optimize the prescription label instructions by
considering reports from the pharmacy practice. Also, the
guideline will be updated continuously, as new insights arise.
The evaluation of comments will be performed in January 2021.
Ethics and Dissemination
The patient studies have been approved by the Ethical
Committee of the Amsterdam UMC, location VU Medical
Centre, The Netherlands. Interview transcripts were
pseudonymized before analysis. All collected data were
preceded by participants’ verbal—audiotaped—informed
consent, and preferably written informed consent too. Results
of this research are expected to be disseminated through peer-
reviewed publications, conference presentations, a PhD thesis,
and presentations for interested stakeholders.DISCUSSION
We proposed a mixed methods study to analyze, optimize, and
implement comprehensible prescription label instructions in the
Netherlands. Our study consisted of four phases, in which a
systematic literature review and a content analysis on
prescription label instructions textual elements and topics were
conducted in the first phase (1a and 1b). To compose
comprehensible prescription label instructions, patients’
perspective should be included. Moreover, it is important to
take health literacy into account when evaluating the
comprehensibility of prescription label instructions (Wallace
et al., 2008). Therefore, in the second phase qualitative and
quantitative patient studies were performed (2a and 2b). We
used both subjective and objective instruments to measure their
health literacy skills reliably. In the third phase, the results were
implemented in a national medication database. In the fourth
phase, results will be evaluated and further improved by using
experiences from patients and pharmacists.
With this study, we optimized prescription label instructions,
and implemented knowledge in pharmacy practice using a mixed-
methods approach. We believe our approach is pertinent, as we
examined the comprehensibility of prescription label instructions
from different perspectives: literature, linguistics, and patients. In
each phase, we consulted an expert panel, consisting of experts in
the fields of health care, health literacy, linguistics, pharmacyJuly 2020 | Volume 11 | Article 981
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medication databases. Studying and optimizing prescription label
instructions with a multidisciplinary team adds value to this study,
and supported the implementation. Therefore, we believe that our
approach is unique, and shows how health professionals can
provide the most essential instructions about medicine use in a
comprehensible way. In addition, the results can also be applied to
the verbal instructions prescribers and pharmacists provide
to patients.
The European Commission published a revision of the
Guideline on the readability of the label and package leaflet of
medicinal products for human use in 2009 (European
Commission, 2009a). This has been an important step in
acknowledging the patient’s perspective in designing and
evaluating medication information, and has contributed to
improved readability and user testing. However, these EU
guidelines do not apply to prescription label instructions.
These labels are designed for individual patients, that use
individual dosage regimens for their medication. We do believe
that comprehensibility of prescription label instructions should
be tested too by user-testing, in a similar procedure as the
Guideline of the European Commission (Van Dijk et al., 2014).
Moreover, research of Borgsteede and Heringa (2019) showed
a substantial proportion of Dutch prescription label instructions
was too complex, and could be optimized by rephrasing them. In
this study, we collected data about the comprehensibility of
dosage instructions, auxiliary label warnings or advices, and
how they are interpreted by patients with limited and adequate
health literacy using a mixed methods approach. This allowed us
to gain insight into the type of textual elements that were too
complex for patients, and specifically for those with limited
health literacy. Additionally, the qualitative data provided
insights in how patients’ interpretation differs from the
interpretation of health care professionals. In addition, by
testing of currently used and optimized prescription label
instructions, we gained insight in which textual elements could
be improved. A guideline for testing prescription label
instructions should be composed, and, we believe that this
study protocol initiates a first step.
This study will also reveal which prescription label
instructions are too difficult to understand because the
instructions are too complex to be put on a prescription label.
The number of words for prescription label instructions is
generally limited, and it is not possible to refer to contextual
information (e.g., about the disease). As a result, this study might
also give suggestions for verbal instructions about the medication
use given by the prescriber and pharmacist or written
instructions in a patient-centered information leaflet.
Integration and adaptation of all information sources into
comprehensible patient information will support patients in
therapy adherence, in particular for patients with limited
(health) literacy.
Strengths and Limitations
A limitation of the study is that no research was included on
graphical elements on prescription label instructions. Due to
the fact that Dutch printing systems do not facilitate printingFrontiers in Pharmacology | www.frontiersin.org 8symbols on the medication label, and our aim to implement
our findings directly, we focused on the wording of
prescription label instructions. Additional elements could
support the comprehension of prescription label instructions.
A systematic review of Sletvold et al. (2019) showed that
pharmaceutical pictograms are useful for patients that are
normally at risk for non-adherence to medication therapy
(Sletvold et al., 2019). Also, Katz et al. concluded a
combination of symbols and textual information were more
effective for patients’ understanding than the use of symbols
only (Katz et al., 2006). Therefore, it is important to investigate
the formulation of prescription label instructions, so that
combining comprehensible prescription label instructions
and graphical e lements could strengthen pat ients ’
comprehension even more.
Another limitation of this this study, is that the use of printed
prescription label instructions varies between countries: although
this is common practice in many Western countries, this is not
always the case in developing countries (U.S. Congress and
O.O.T.A., 1993). We believe this protocol will identify general
problems in the comprehension of information regarding
medication use, and give a direction how these problems can
be solved. Therefore, this research is also relevant for the
countries that do not use prescription label instructions yet, as
the results will enable health professionals to give comprehensible
instructions in their verbal communication.
We included experiences of patients, both with adequate and
limited health literacy, and analyze them using both qualitative
and quantitative methods. This study identifies general problems
concerning the comprehension of medication use instructions,
and provide potential solutions that will improve the
comprehensibility of prescription labels instructions which can
also be applied to verbal communication. Also in verbal
communication, clear communication is hampered by limited
health literacy (Howard et al., 2013).
In conclusion, this study protocol describes a method to
compose and implement comprehensible prescription label
instructions. This will lead to better comprehension for
patients, which in turn might lead to better adherence.ETHICS STATEMENT
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